Biotech

Critical Outcome Technologies Inc. Selected for Trade Mission to BioPartnering North America

LONDON, ONTARIO: ...

The Medicines Company Reports Full Year and Fourth Quarter 2011 Financial Results

PARSIPPANY, NJ: Full Year EPS Is $2.35 per Share vs Year Ago $1.97, Revenues of $484.7 Million vs Year Ago $437.6 Million ...

Paladin to Present at the RBC Capital Markets Healthcare Conference in New York City

MONTREAL, CANADA: ...

Novo Energies Corporation Announces Dr. Michael Har-Noy's Seminar to The Johns Hopkins Institute for Cell Engineering

NEW YORK, NY: ...

Paladin Announces Strategic Partnership with Litha and Merging of South African Pharmaceutical Businesses

MONTREAL, CANADA: - Paladin Labs becomes Litha's largest shareholder and international strategic partner - Litha Healthcare Group to purchase 100% of Pharmaplan (Pty) Ltd and to merge Litha Pharma Division with Ph ...

Horizon Pharma to Present at the Cowen and Company Health Care Conference

DEERFIELD, IL: ...

Genetic Technologies Successfully Concludes Second Patent Infringement Suit in USA

MELBOURNE, AUSTRALIA: ...

Corcept Therapeutics Incorporated Announces FDA Approval of Korlym(TM) (Mifepristone): First and Only Approved Medication for Cushing's Syndrome Patients

MENLO PARK, CA: ...

ProMetic Improves its Short Term Liquidity by $5.0 Million

LAVAL, QUEBEC, CANADA: ...

Threshold Pharmaceuticals Appoints Dr. Tillman Pearce as Chief Medical Officer

SOUTH SAN FRANCISCO, CA: ...